UBS Group AG - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 38 filers reported holding ELOXX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$12,000
-47.8%
21,849
+87.8%
0.00%
Q2 2021$23,000
+27.8%
11,635
+109.3%
0.00%
Q1 2021$18,000
-25.0%
5,559
-6.8%
0.00%
Q4 2020$24,000
+4.3%
5,963
-21.5%
0.00%
Q2 2020$23,000
-20.7%
7,601
-48.1%
0.00%
Q1 2020$29,000
-88.1%
14,641
-55.6%
0.00%
Q4 2019$243,000
+291.9%
32,948
+140.1%
0.00%
Q3 2019$62,000
+313.3%
13,725
+973.1%
0.00%
Q4 2018$15,000
-85.8%
1,279
-79.5%
0.00%
Q3 2018$106,000
+146.5%
6,224
+148.3%
0.00%
Q2 2018$43,0002,5070.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MENORA MIVTACHIM HOLDINGS LTD. 1,882,456$22,608,0000.65%
New England Private Wealth Advisors LLC 130,557$1,568,0000.46%
Altshuler Shaham Ltd 841,663$10,108,0000.44%
MEITAV INVESTMENT HOUSE LTD 516,543$6,204,0000.38%
EMERALD MUTUAL FUND ADVISERS TRUST 200,000$2,402,0000.11%
MetLife Investment Management, LLC 14,403$172,9800.00%
METROPOLITAN LIFE INSURANCE CO/NY 10,172$122,1660.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 34,915$419,0000.00%
TEACHERS ADVISORS, LLC 40,748$489,0000.00%
Tower Research Capital LLC (TRC) 848$10,0000.00%
View complete list of ELOXX PHARMACEUTICALS INC shareholders